97 related articles for article (PubMed ID: 7764073)
1. Enzymatic production of optically pure (2'R-cis)-2'-deoxy-3'-thiacytidine (3TC, lamivudine): a potent anti-HIV agent.
Mahmoudian M; Baines BS; Drake CS; Hale RS; Jones P; Piercey JE; Montgomery DS; Purvis IJ; Storer R; Dawson MJ
Enzyme Microb Technol; 1993 Sep; 15(9):749-55. PubMed ID: 7764073
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective enzymatic biotransformation of 2'-deoxy-3'-thiacytidine (BCH 189) monitored by capillary electrophoresis.
Rogan MM; Drake C; Goodall DM; Altria KD
Anal Biochem; 1993 Feb; 208(2):343-7. PubMed ID: 8383931
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
[TBL] [Abstract][Full Text] [Related]
4. The intracellular phosphorylation of (-)-2'-deoxy-3'-thiacytidine (3TC) and the incorporation of 3TC 5'-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase gamma.
Gray NM; Marr CL; Penn CR; Cameron JM; Bethell RC
Biochem Pharmacol; 1995 Sep; 50(7):1043-51. PubMed ID: 7575660
[TBL] [Abstract][Full Text] [Related]
5. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase.
Shewach DS; Liotta DC; Schinazi RF
Biochem Pharmacol; 1993 Apr; 45(7):1540-3. PubMed ID: 8385948
[TBL] [Abstract][Full Text] [Related]
6. Cellular metabolism of (-) enantiomeric 2'-deoxy-3'-thiacytidine.
Cammack N; Rouse P; Marr CL; Reid PJ; Boehme RE; Coates JA; Penn CR; Cameron JM
Biochem Pharmacol; 1992 May; 43(10):2059-64. PubMed ID: 1318048
[TBL] [Abstract][Full Text] [Related]
7. The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro.
Coates JA; Cammack N; Jenkinson HJ; Mutton IM; Pearson BA; Storer R; Cameron JM; Penn CR
Antimicrob Agents Chemother; 1992 Jan; 36(1):202-5. PubMed ID: 1590690
[TBL] [Abstract][Full Text] [Related]
8. Renal disposition and drug interaction screening of (-)-2'-deoxy-3'-thiacytidine (3TC) in the isolated perfused rat kidney.
Sweeney KR; Hsyu PH; Statkevich P; Taft DR
Pharm Res; 1995 Dec; 12(12):1958-63. PubMed ID: 8786973
[TBL] [Abstract][Full Text] [Related]
9. Determination of 2'-deoxy-3'-thiacytidine (3TC) in human urine by liquid chromatography: direct injection with column switching.
Morris DM; Selinger K
J Pharm Biomed Anal; 1994 Feb; 12(2):255-64. PubMed ID: 8003552
[TBL] [Abstract][Full Text] [Related]
10. Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.
Chang CN; Doong SL; Zhou JH; Beach JW; Jeong LS; Chu CK; Tsai CH; Cheng YC; Liotta D; Schinazi R
J Biol Chem; 1992 Jul; 267(20):13938-42. PubMed ID: 1321132
[TBL] [Abstract][Full Text] [Related]
11. Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (--)-2',3'-dideoxy-3'-thiacytidine.
Kavlick MF; Shirasaka T; Kojima E; Pluda JM; Hui F; Yarchoan R; Mitsuya H
Antiviral Res; 1995 Oct; 28(2):133-46. PubMed ID: 8585767
[TBL] [Abstract][Full Text] [Related]
12. The biochemical basis for the differential anti-human immunodeficiency virus activity of two cis enantiomers of 2',3'-dideoxy-3'-thiacytidine.
Skalski V; Chang CN; Dutschman G; Cheng YC
J Biol Chem; 1993 Nov; 268(31):23234-8. PubMed ID: 7693686
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.
Harker AJ; Evans GL; Hawley AE; Morris DM
J Chromatogr B Biomed Appl; 1994 Jul; 657(1):227-32. PubMed ID: 7952073
[TBL] [Abstract][Full Text] [Related]
14. Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex.
Wainberg MA; Salomon H; Gu Z; Montaner JS; Cooley TP; McCaffrey R; Ruedy J; Hirst HM; Cammack N; Cameron J
AIDS; 1995 Apr; 9(4):351-7. PubMed ID: 7540846
[TBL] [Abstract][Full Text] [Related]
15. Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes.
Schinazi RF; Chu CK; Peck A; McMillan A; Mathis R; Cannon D; Jeong LS; Beach JW; Choi WB; Yeola S
Antimicrob Agents Chemother; 1992 Mar; 36(3):672-6. PubMed ID: 1320365
[TBL] [Abstract][Full Text] [Related]
16. A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection.
Pluda JM; Cooley TP; Montaner JS; Shay LE; Reinhalter NE; Warthan SN; Ruedy J; Hirst HM; Vicary CA; Quinn JB
J Infect Dis; 1995 Jun; 171(6):1438-47. PubMed ID: 7769277
[TBL] [Abstract][Full Text] [Related]
17. In vitro immunotoxicity of +/- 2'-deoxy-3'-thiacytidine, a new anti-HIV agent.
Lisignoli G; Monaco MC; Degrassi A; Toneguzzi S; Ricchi E; Costigliola P; Facchini A
Clin Exp Immunol; 1993 Jun; 92(3):455-9. PubMed ID: 8390335
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109.
Balzarini J; Wedgwood O; Kruining J; Pelemans H; Heijtink R; De Clercq E; McGuigan C
Biochem Biophys Res Commun; 1996 Aug; 225(2):363-9. PubMed ID: 8753770
[TBL] [Abstract][Full Text] [Related]
19. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
Anderson KS
Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
